BioGaia AB ser. B (BIOGb)

93.3
-0.4(-0.46%)
  • Volume:
    37,949
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    92.9 - 94.0

BIOGb Overview

Prev. Close
93.7
Day's Range
92.9-94
Revenue
951.95M
Open
93.7
52 wk Range
84.8-125.6
EPS
2.44
Volume
37,949
Market Cap
9.42B
Dividend (Yield)
3.63
(0.78%)
Average Volume (3m)
98,845
P/E Ratio
39.24
Beta
0.595
1-Year Change
0.97%
Shares Outstanding
100,982,310
Next Earnings Date
20 Oct 2022
What is your sentiment on BioGaia B?
or
Market is currently closed. Voting is open during market hours.

BioGaia AB ser. B Company Profile

BioGaia AB ser. B Company Profile

Employees
189
Market
Sweden
  • Type:Equity
  • Market:Sweden
  • ISIN:SE0017769995
  • S/N:19455794

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellNeutralNeutralSellNeutral
Technical IndicatorsSellSellStrong SellStrong SellSell
SummaryStrong SellNeutralSellStrong SellNeutral